Hosted on MSN

Six-year-old Chinese girl sets new Rubik's Cube world record with average time under 4.5 seconds

Lian Yunzhi broke the record for the 3x3x3 puzzle twice in just three days during competitions in Wuhan and Guangzhou. The youngster completed five solves with an average time of 4.52 seconds before ...
Yahoo Finance

Energy Transfer LP (ET)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Center for a New American Security

Behind the Front Line

Integrating AI Agents into Joint Force Support Functions ...
Investopedia

The Federal Trade Commission (FTC): Functions and Responsibilities

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Kotaku

LP Recharge

All the Latest Game Footage and Images from LP Recharge LP Recharge, also known as Linkin Park Recharge, is a free-to-play action-puzzle game, developed by Swiss studio Kuuluu Interactive ...
Workiva

Using Knowledge for LP Quarterly Reporting

The video demonstrates how WorkivaAI and the Workiva Knowledge base assist asset managers in automating complex quarterly reporting for limited partners. It showcases a specific workflow where the AI ...
pharmaphorum

Chasing Novartis, Amgen ushers Lp(a) drug into phase 3

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Healio

‘Not the results we hoped for’: Lp(a)-lowering drug pelacarsen fails to reduce CV events

Please provide your email address to receive an email when new articles are posted on . Pelacarsen did not reduce cardiovascular events in patients with elevated lipoprotein(a) compared with placebo.
CNBC

Cholesterol drug setback casts doubt over multibillion-dollar race

Novartis’ pelacarsen failed to reduce cardiovascular events despite lowering the harmful cholesterol Lp(a). The setback raises uncertainty for rival experimental Lp(a) drugs from Amgen and Eli Lilly.
TCTMD

Lp(a)HORIZON: Top-line Results Dash Hopes for Pelacarsen

The much-anticipated Lp(a)HORIZON trial testing whether the novel drug pelacarsen can improve cardiovascular outcomes by decreasing lipoprotein(a) levels has failed to meet its primary endpoint.
GitHub

GPU-Presolver

GPU-Presolver is a C++/CUDA package for GPU-based LP presolve and postsolve. It reduces a linear program before an external solver solves it, then recovers a solution in the original model space. The ...